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Objective: Cone beam CT (CBCT) enables soft-tissue
registration to planning CT for position verification in
radiotherapy. The aim of this study was to determine the
interobserver error (IOE) in prostate position verification
using a standard CBCT protocol, and the effect of reducing
CBCT scan length or increasing exposure, compared with
standard imaging protocol.
Methods: CBCT images were acquired using a novel 7cm
length image with standard exposure (1644mAs) at Frac-
tion 1 (7), standard 12cm length image (1644mAs)
at Fraction 2 (12) and a 7cm length image with higher
exposure (2632mAs) at Fraction 3 (7H) on 31 patients
receiving radiotherapy for prostate cancer. Eight observers
(two clinicians and six radiographers) registered the images.
Guidelines and training were provided. The means of the
IOEs were compared using a Kruzkal–Wallis test. Levene’s
test was used to test for differences in the variances of the
IOEs and the independent prostate position.
Results: No significant difference was found between
the IOEs of each image protocol in any direction.
Mean absolute IOE was the greatest in the anteropos-
terior direction. Standard deviation (SD) of the IOE
was the least in the left–right direction for each of the
three image protocols. The SD of the IOE was
significantly less than the independent prostate mo-
tion in the anterior–posterior (AP) direction only
(1.8 and 3.0mm, respectively: p50.017). IOEs were
within 1 SD of the independent prostate motion in 95%,
77% and 96% of the images in the RL, SI and AP
direction.
Conclusion: Reducing CBCT scan length and increasing
exposure did not have a significant effect on IOEs. To
reduce imaging dose, a reduction in CBCT scan length
could be considered without increasing the uncertainty in
prostate registration. Precision of CBCT verification of
prostate radiotherapy is affected by IOE and should be
quantified prior to implementation.
Advances in knowledge: This study shows the impor-
tance of quantifying the magnitude of IOEs prior to CBCT
implementation.
INTRODUCTION
The use of intraprostatic gold markers has improved the
accuracy of radiotherapy treatment to the prostate by pro-
viding a surrogate of the prostate position which is visible on
kVor MV X-ray imaging.1,2 However, information regarding
deformation of the prostate and organs at risk is not avail-
able on 2D planar imaging. The implementation of in-room
CT imaging devices has provided 3D information to quan-
tify target motion, rotation and deformation in addition to
movement of organs at risk.3–5 This enables online 3D im-
aging, soft-tissue registration and has the potential to reduce
planning target volume (PTV) margins, allowing dose es-
calation with the aim to improve the therapeutic ratio.
Whilst online imaging reduces the uncertainties associated
with the prostate position, residual errors will remain. One
source of residual error is interobserver error (IOE) which
has been shown to be signiﬁcant, albeit with the majority of
the studies exporting the cone beam CT (CBCT) and con-
touring the prostate on treatment planning systems which is
not replicating registration at the treatment console.5–10
IOEs gave a standard deviation (SD) of contoured prostate
volumes as great as 20% of the average prostate volume
(10) and a SD of IOE of .2mm was found.5,8 A common
ﬁnding in all studies was greater interobserver variation
in the SI direction.5–10 This is consistent with studies
which investigated interobserver on CT images.11–13 A
few studies have compared CBCT with 2D imaging devices14,15
and found that compared with kV imaging of intraprostatic
ﬁducial markers, there were differences in set-up errors of
.3mm in the SI and AP direction14 and an additional 1mm
margin was required, when using CBCT without intraprostatic
ﬁducial markers.15 Although IOEs were not investigated, it was
postulated that these differences were, in part, due to the difﬁ-
culty in visualizing the prostate on the CBCT images.
The above studies demonstrate that IOEs should be consid-
ered when using 3D imaging without gold markers for veri-
ﬁcation and deﬁning planning treatment volume margins. It
may also be appropriate to investigate the methods of reducing
IOEs. Currently in our department, CBCT images for prostate
veriﬁcation radiotherapy are acquired using XVI v. 4.5 (Elekta
Oncology Systems, Crawley, UK). The imaging options can be
selected from a choice of small, medium and large, ﬁeld of
view (FOV) equating to approximately 26, 40 and 52 cm di-
ameter FOV and three ﬁeld lengths 10, 15 and 20 equating to
12, 17 and 26 cm length at the isocentre. The standard imaging
protocol for the prostate at our centre is a 12 cm scan length,
40 cm FOV (M10) and 1644mAs exposure resulting in a cone
beam CT dose index (CTDI) of 27mGy. All the scans for this
study are medium FOV, and we refer to the length by the
actual lengths, i.e. 12 cm for standard and 7 cm for the
test length.
One method to reduce IOEs might be to improve the visu-
alization of the prostate by improving CBCT image quality.
We propose that the image quality of our standard CBCT
images would be improved if a smaller length of tissue
was imaged thereby reducing the amount of scattered radi-
ation which has the beneﬁt of reduced integral dose. We
also propose to investigate if reducing image scan length
increasing the X-ray exposure improves image quality and
reduces IOE.
The aim of this study was to ﬁrstly, determine IOE in de-
termining prostate position on CBCT images acquired using
standard protocol. Secondly, to investigate if reducing the scan
Figure 1. Cone beam CT acquired using (a) standard 13 cm length (M10; 1644mAs), (b) 7 cm length standard dose (M5; 1644mAs)
and (c) 7 cm length high dose (M5; 2632mAs).
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length or increasing the exposure affects the magnitude of IOE.
IOEs associated with registering the prostate position on CBCT
images to planning CT scans were determined using our stan-
dard CBCT image protocol (12 cm and 1644mAs) and com-
pared to those obtained when using:
(1) a reduced CBCT scan length with the same X-ray exposure
(7 cm and 1644mAs) giving a reduced integral dose
compared with the standard protocol. The dose length
product is reduced from 324 to 189mGy*cm.
(2) a reduced CBCT scan length and increased X-ray exposure
(7 cm and 2632mAs : CTDI 43.2mGy) giving equivalent
integral dose to the standard protocol. The dose length
product is 302mGy*cm.
IOEs using CBCT were compared with independent prostate
motion and the accuracy of prostate position measurement us-
ing automated software match.
METHODS AND MATERIALS
Patients referred for radical radiotherapy to the prostate and
seminal vesicles were recruited for the study, which was ap-
proved by the local research and ethics committees. Patients
were immobilized using the Combi Fix system (Oncology Sys-
tems Ltd, Shropshire, UK) and had been given information sheet
detailing instructions regarding maintenance of a comfortable
full bladder throughout treatment. Planning CT scans were ac-
quired with 3-mm slice thickness. If patients had an ante-
roposterior rectal dimension of .4 cm at the time of CT
planning then the patient was rescanned. If the rectum was
distended due to faeces rather than gas, enemas were prescribed
for the repeat scan and during treatment. Patients were treated
using a three ﬁeld forward planned intensity modulated radio-
therapy treatment (Pinnacle; Philips) delivered in either 2Gy
and 37 fractions or 3Gy and 20 fractions.
Prior to treatment delivery, CBCT images were acquired
using a novel 7 cm length image with standard exposure
(1644 mAs) at Fraction 1 (7), standard 12 cm length image
(1644 mAs) at Fraction 2 (12) and a 7 cm length image with
higher exposure (2632mAs) at Fraction 3 (7H) (Figure 1).
The remainder of veriﬁcation images used the standard
length and exposure.
Patients were positioned to skin marks and the isocentre po-
sition set according to plan set-up. CBCT images were regis-
tered to planning CT images retrospectively by eight observers
(two clinicians and six radiographers) (Elekta Synergy® XVI v.
4.5; Crawley, UK) using treatment console software (XVI v. 4;
Elekta Oncology Systems). Guidelines and training were pro-
vided for the observers which included identiﬁcation and
comparison of the prostate in images acquired by MRI, CT and
CBCT. Observers were asked to ﬁrstly register the images using
bony anatomy and then manually adjust, where necessary,
using soft tissue. To do this, the observer deﬁned a region of
interest which was used by the software to perform automated
rigid registration to bony anatomy (chamfer matching). The
observer visually checked the registration of the prostate and
manually adjusted the registration if necessary to obtain
a closer match. Observers recorded prostate position (this was
the total set-up error including both patient and prostate
displacement) and whether manual adjustment had been per-
formed. In addition, they indicated their conﬁdence in
the prostate match on a visual analogue scale of 0–10, where 0
was not conﬁdent and 10 was very conﬁdent. Patient width,
laterally and anteroposterior, and the presence of gas in the
images were also recorded to evaluate their effect on IOEs. In
addition, one observer registered the images using the auto-
matic dual registration software. This ﬁrstly registers the bony
anatomy position, followed by the “greyscale” registration
(cross correlation) to the soft tissue using an irregular region of
interest (mask) deﬁned automatically as the clinical target
volume of the prostate plus 0.5 cm margin. It was ensured that
there was no bony anatomy included in the mask since this
would affect the soft-tissue registration.
Statistical analysis
For each patient, the average prostate position, across all the
observers, provided an estimate of the “gold standard”
Table 1. Interfraction set-up displacements
Translational direction
Total set-up errors (patient and prostate) Independent prostate motion
Mean (SD) Median (range) Mean (SD) Median (range)
Right–left (mm) 20.6 (2.8) 0.7 (5.9–5.6) 20.2 (0.9) 0 (25.4 to 0.9)
Superior–Inferior (mm) 1.2 (2.4) 1.0 (3.7–8.7) 0.10 (1.9) 0.2 (23.7 to 3.9)
Anterior–posterior (mm) 0.5 (3.6) 0.2 (10.7–7.8) 21.1 (3.0) 0.3 (212 to 4)
Where left is positive sign, superior is positive sign and anterior is positive sign.
Table 2. Mean (standard deviation) of interobserver errors in each direction and image type
Cone beam CT image type Right–left (mm) Superior–inferior (mm) Anterior–posterior (mm)
7 cm standard exposure (n5 31) 0.4 (0.5) 1.2 (0.9) 1.6 (0.8)
12 cm standard exposure (n5 31) 0.4 (0.3) 1.4 (0.9) 1.6 (0.7)
7 cm high exposure (n5 30) 0.5 (0.5) 1.5 (1.0) 1.8 (0.8)
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prostate position (total set-up displacement). To determine
independent prostate motion, the bony anatomy positions
were subtracted from the prostate position to determine in-
dependent prostate motion and to compare that found by
other studies.
The IOE for each image was calculated as the SD of the prostate
displacement recorded by all eight observers. IOE were tested for
normality using a Quantile–Quantile probability plot (Q–Q
plot). To compare the means of the IOEs between the three
different imaging protocols, a non-parametric unrelated samples
test, Kruzkal–Wallis, was used.
Patient size (lateral width and anteroposterior depth) and the
presence of gas in the images were also recorded and the effect
on IOEs was determined using a Spearman’s rank correlation
coefﬁcient and Mann–Whitney U-test independent samples
U-test, respectively. The relationship between the visual ana-
logue score and IOE was assessed using Spearman’s rank cor-
relation coefﬁcient.
To enable clinical implementation of CBCT soft-tissue imag-
ing, we deﬁned that the uncertainty in the registration should
be less than the uncertainty of using bony anatomy. Non-
parametric Levene’s test was used to test if the variances of the
IOEs and the independent prostate position were equal or
different.
The automatic greyscale registrations were compared to the
observer registrations to determine the magnitude and fre-
quency of manual adjustments.
RESULTS
Set-up errors
93 CBCT images were acquired in 31 patients (3 per patient) and
the mean (SD) and median (range) of the total set-up interfraction
errors (patient and prostate displacement) are shown in Table 1.
Interobserver errors
The mean IOE was the greatest in the AP direction for each of
the three image protocols but the SD of the IOE was greater in
the SI direction (Table 2).
No signiﬁcant difference was found between the IOEs in any
direction between the image protocols; therefore, the IOEs were
analysed using all images from hereon in. There was also no
signiﬁcant difference between the two clinicians’ results and the
six radiographers’ results.
The SD of the IOE was signiﬁcantly less (p5 0.017) than the
independent prostate motion in the AP direction only (Table 3).
IOEs were not signiﬁcantly different to independent prostate
motion in the LR and SI directions.
The IOEs were within 1SD of the independent prostate motion
in 95%, 77% and 96% of the images in the RL, SI and AP
direction (Figure 2a–c). The IOE was greater when there was gas
present in the CBCT image in the RL (p5 0.03) and AP di-
rection (p5 0.01). There was no signiﬁcant difference in the SI
direction. The IOEs were not affected by patient dimensions.
The conﬁdence score measured with the visual analogue scale was not
correlated with the IOE in the RL and SI direction but as conﬁdence
increased the IOE decreased (r50.6; p50.01) in the AP direction.
Comparison of observer registrations and
automatic registrations
The average interobserver registration correlated strongly (Pear-
son’s product–moment correlation coefﬁcient) with the automatic
“greyscale” match in the RL direction (r5 0.89; p5 0.01 and less
strongly in the SI direction (r5 0.78; p5 0.01) and AP direction
(r5 0.58; p5 0.01).
The difference between the observer registrations and greyscale
registrations was .3mm in 5%, 21% and 15% of the images
and .5mm in 2%, 11% and 8% of the images in the RL, SI and
AP directions, respectively. The registration was manually ad-
justed in 42% of registrations.
DISCUSSION
Increasing the dose and reducing the length of the CBCT did
not have a signiﬁcant effect on the IOEs. We found the IOEs of
CBCT registration with planning CT to be of a magnitude that
ought to be considered a component of the residual error. Residual
errors can arise from geometrical uncertainties (phantom transfer
error), errors with the position measurement and inaccurate couch
movement, IOEs associated with CBCT and planning CT registra-
tion or patient motion. The SD of residual errors due to mechanical
couch movement is reported to be in range of 0.8–1.6mm.16,17
Residual errors .2mm are generally thought to be due to prostate
motion;17–19 however, these studies investigated residual error with
pre- and post-treatment images, and subsequent investigations have
shown that large prostate motions during treatment can be tran-
sient.20 Our study has shown that IOEs from soft-tissue registrations
are similar in magnitude to other sources of residual error and
therefore should be quantiﬁed and taken into account when cal-
culating clinical target volume (CTV) to PTV margins.







Right–left 0.6 1.0 0.82
Superior–inferior 1.6 1.9 0.51
Anterior–posterior 1.8 3.0 0.01
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Figure 2. Interobserver errors (mm) as related to SD of prostate motion in, RL (a); SI (b); AP (c); directions.
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The SD of observer displacements was signiﬁcantly less than that
of the independent prostate motion in one direction only (AP).
Comparing the IOEs to a standard 2mm tolerance used in ra-
diotherapy 1%, 13% and 16% of images in the RL, SI and AP
directions, respectively had IOEs of .2mm. This suggests that
centres considering using soft-tissue CBCT match rather than
bony anatomy matching, and it is important that IOEs are
quantiﬁed and compared to expected independent prostate
motion. If observer errors are greater, there may be no beneﬁt
from using CBCT soft-tissue match.
The greater magnitude of manual moves in the SI direction could
be explained by the known difﬁculty in assessing prostate position
in CT scans in this direction.11–13 However, the 3-mm slice
thickness of the reference CT planning may also contribute to the
larger discrepancies on the SI direction. In addition, the difﬁculty
in visualizing the prostate (made worse by blurring because of gas
pockets) may also have affected the registrations in all directions.
The lack of “ground truth” of the prostate motion is a weakness
of this study; however, the distribution of the set-up errors of
both patient and prostate is within expected ranges compared
with previously published results.1,2,21,22
Reducing the length of the scan and increasing the dose did not
improve IOEs, and we suggest that other methods of decreasing
IOEs are investigated. Possible solutions to aid image registration
include implanting ﬁducial markers and with the 3D imaging
would still provide the additional soft-tissue information re-
garding organs at risk position and deformation of the target
compared with kVor MV planar imaging. Improved training for
radiographers may decrease IOE; however, two of these
observers were clinicians and the mean of the radiographers and
the mean of the clinicians were not signiﬁcantly different. This
agreement suggests that for routine clinical practice prostate
matching does not require clinician intervention. Furthermore,
routine practice involves two radiographers when checking the
ﬁnal registration which has been shown to make a difference in
concordance when selecting PTV for bladder patients.23 Re-
ducing the slice thickness of the planning CT scan may decrease
the error in the SI direction. However, the ﬁndings of this study
have highlighted that reducing the scan length did not increase
IOEs, and therefore a reduction in scan length may beneﬁt
patients, by reducing integral dose with no loss of precision.
CONCLUSION
Reducing CBCT scan length and increasing exposure did not
have a signiﬁcant effect on IOEs. To reduce imaging dose, a re-
duction in CBCT scan length could be considered without in-
creasing the uncertainty in prostate registration. Precision of
CBCT veriﬁcation of prostate radiotherapy is affected by IOE
which should be quantiﬁed prior to implementation.
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